Trial Profile

Phase III trial of COVID-19 vaccine.

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 27 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs COVID-2019 vaccine-Shenzhen Kangtai Biological Products (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

27 Jun 2021 New trial record
22 Jun 2021 According to a Shenzhen Kangtai Biological Products media release, phase III clinical fieldwork was initiated and first batch of enrolled subjects was vaccinated on-site.
22 Jun 2021 According to a Shenzhen Kangtai Biological Products media release, BIOKANGTAI and Malaysia's Yong Tai Berhad signed an Agreement to conduct this study in February.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com